Quick Facts
- Sample: Blood draw
- Fasting: Not required
- Turn-around: 2-3 business days. May take longer based on weather, holiday, or lab delays.
Benefits
- Comprehensive screening - Tests for infections, blood compatibility, and chromosomal abnormality risks in one panel
- Faster results - Get results in 2-3 days versus up to a week with traditional healthcare
- No insurance hassles - Direct-pay pricing eliminates pre-authorization delays and surprise bills
- Convenient access - Walk-in testing with no appointment or doctor's referral required
- HIPAA-compliant - Secure online portal protects your sensitive health information
Who Is This Test For?
- Pregnant women in second trimester (15-20 weeks) seeking comprehensive prenatal screening
- Expectant mothers wanting to assess infection risks and blood compatibility factors
- High-risk pregnancies requiring careful monitoring for chromosomal abnormalities
- Women with limited healthcare access needing direct-to-consumer testing options
- Anyone preferring transparent pricing without insurance complications
- First-time mothers seeking peace of mind about maternal and fetal health
How It Works – Just 3 Steps
- Visit any Walk-In Lab location - No appointment needed, bring photo ID
- Quick blood draw - Certified phlebotomist collects sample in under 10 minutes
- Get secure results - Access results online within 2-3 days
FAQ
What infections does this panel test for? Tests for hepatitis B, HIV-1/2, syphilis, and rubella immunity status to protect both mother and baby.
When is the best time to take this test? Optimal timing is 16-18 weeks of pregnancy, though the testing window extends from 15-20 weeks.
Do I need to fast before the test? No fasting is required for this prenatal blood panel.
What if my results are abnormal? Abnormal results require immediate physician consultation and may warrant additional testing or treatment.
More Details
What is the purpose of this test?
The Morgan Prenatal Blood Test Panel #2 provides comprehensive second-trimester screening that combines multiple biomarkers to assess both maternal health and fetal well-being (ACOG 2024). This panel screens for infectious diseases including hepatitis B, HIV, and syphilis that could affect pregnancy outcomes. It also determines blood type and Rh factor for compatibility assessment, evaluates rubella immunity status, and incorporates maternal serum markers like alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG) to screen for chromosomal abnormalities such as Down syndrome and neural tube defects.
Who would benefit from this test?
All pregnant women in their second trimester should consider this comprehensive screening, particularly those seeking direct-access testing without insurance complications (CDC 2023). Women with limited healthcare access, those preferring transparent pricing, and expectant mothers wanting faster results than traditional healthcare pathways will find significant value. High-risk pregnancies requiring careful monitoring and first-time mothers seeking peace of mind about maternal and fetal health are especially good candidates for this panel.
When should I order a Morgan Prenatal Blood Test Panel #2?
The optimal testing window is between 16-18 weeks of pregnancy for maximum accuracy of maternal serum screening, though the panel can be performed from 15-20 weeks gestation (Mayo Clinic 2024). Earlier testing may yield less accurate chromosomal screening results, while later testing may limit intervention options if abnormalities are detected.
How do I interpret the results?
Hepatitis B Surface Antigen
- Normal Result: Negative
- Abnormal Action: Immediate treatment, newborn vaccination
HIV-1/2
- Normal Result: Negative
- Abnormal Action: Antiviral therapy, transmission prevention
RPR (Syphilis)
- Normal Result: Non-reactive
- Abnormal Action: Antibiotic treatment
Rubella IgG
- Normal Result: Immune (≥10 IU/mL)
- Abnormal Action: Avoid exposure, post-delivery vaccination
Universal prenatal screening for hepatitis B combined with infant vaccination reduces mother-to-child transmission by over 95% (NHS 2024).
Disclaimer: Reference ranges may vary by laboratory. Listed ranges are general guidelines and may differ from those used by the performing lab. Always consult your healthcare provider for interpretation.
Pre-test preparation
No fasting is required for this blood panel. Avoid medications that might interfere with hormone levels unless medically necessary. Bring photo identification and any relevant medical history to your Walk-In Lab location. Schedule testing between 15-20 weeks gestation for optimal screening accuracy. No special dietary restrictions or preparation steps are needed before your blood draw.
How often should I get tested?
- Standard pregnancy: Once during the second trimester
- High-risk pregnancy: As recommended by physician
- Previous abnormal results: Follow-up testing per provider guidance
- Multiple pregnancies: Each pregnancy requires fresh screening
Why early detection matters
Early identification of infections during pregnancy enables timely intervention to prevent serious complications for both mother and baby. Untreated hepatitis B can result in chronic infection in 90% of infected newborns, while HIV transmission can be reduced from 25% to less than 2% with proper treatment (CDC 2023). Chromosomal abnormality screening provides crucial information for pregnancy management decisions and enables early intervention planning.
Related tests you may consider
Pregnancy Progression Blood Test Panel – Measures quantitative hCG and progesterone levels to monitor early pregnancy development. hCG confirms pregnancy and tracks progression, while progesterone supports a healthy uterine environment and helps maintain pregnancy.
Gestational Glucose Tolerance Diagnostic Blood Test, 3-Hour – Follows ACOG guidelines to diagnose gestational diabetes. After fasting, blood glucose levels are measured over three hours following a 100g glucose drink to assess how the body processes sugar during pregnancy.
Prenatal Profile (OB) Blood Test Panel – Evaluates key health indicators during early pregnancy, including blood type, Rh factor, anemia, and infections such as HIV and syphilis, to help protect both mother and baby.